ODDITY Tech (ODD) spent two years as the rare profitable, fast-growing DTC beauty platform — FY2025 net revenue rose 25% to $810M at a ~72.5% gross margin with ~$2.10+ adjusted EPS — but the stock has collapsed ~83% from a $79 high to roughly $13 (market cap ~$745M). The break came in Q1'26: a technical algorithm change at ODDITY's largest advertising partner pushed spend into low-quality auctions, spiking customer-acquisition cost (CPA) at flagship IL MAKIAGE. Revenue fell 26% to $197.9M, the company swung to a −$21.4M net loss (adj. EPS −$0.17 vs ~−$0.04 est.), adjusted EBITDA went to −$7M, and management suspended FY2026 guidance — guiding only Q2 revenue down 25–30% with adj. EBITDA back to $8–10M positive. The balance sheet is the bull's anchor: $667M cash + investments, no debt, and an active $200M buyback ($82M repurchased in Q1, cutting Class A shares ~10.6%). Sell-side turned sharply negative — Goldman cut to Sell ($8), Barclays Underweight ($8), BofA Underperform ($8.50), Morgan Stanley Equal Weight ($10) — with the average PT down ~71% in 90 days. The debate is binary: a fixable platform glitch on a structurally advantaged tech platform, or evidence that the AI/data "moat" was really paid-acquisition arbitrage. We rate HOLD — the valuation has reset toward beauty-peer levels, but with no guidance and an unproven fix, conviction stays Medium until the Q2 print confirms normalization.
| Company | P/E | EV/Rev | Rev Growth | Gross Margin |
|---|---|---|---|---|
| ODDITY Tech | ~12x | ~0.7x | −26% (Q1'26) | ~70% |
| e.l.f. Beauty | ~40x | ~5x | ~+10-15% | ~70% |
| Coty | ~15x | ~1.8x | ~low-single | ~65% |
| Estee Lauder | ~30x | ~2.5x | ~flat/neg | ~72% |
| Scenario | Price Target | Assumptions | Probability |
|---|---|---|---|
| Glitch Fixed, Platform Re-rates | $26 | CPA normalizes by H2'26, IL MAKIAGE re-accelerates, Brand 3/medical launches land, and the AI/data platform thesis (vs. pure ad arbitrage) is vindicated. Revenue returns to double-digit growth in 2027, EBITDA margin rebuilds toward high-teens, and the stock re-rates toward a tech-DTC multiple off a washed-out base. | 30% |
| Slow Normalization, Beauty Multiple | $14 | CPA pressure eases gradually; FY2026 revenue still down meaningfully YoY but adj. EBITDA stays positive. Growth resumes in 2027 at a slower, more discount-retailer pace. Buyback supports the float. Stock trades as a consumer-staples beauty name near current levels, not a software multiple. | 45% |
| Moat Was Ad Arbitrage | $8 | The 'AI moat' proves to have been paid-acquisition dependent; CPA pressure persists or competition (ELF, TikTok-native brands) compounds it. Growth stays negative through 2026, EBITDA disappoints, and the stock converges to the cluster of Sell/Underweight $8 targets — a low-growth beauty company with eroding unit economics. | 25% |